Nvidia in Talks to Anchor Chip Designer Arm ’s IPO, FT Says
Arm Ltd., the chip designer backed by SoftBank Group Corp., is in talks with Nvidia Corp. to join a group of potential investors to anchor its initial public offering, according to the Financial Times. • None Singapore Minister Faces Most Serious Graft Probe Since 1986 • None DeSantis Says No…#armltd #softbankgroupcorp #nvidiacorp #federalenergyfunds #buyactivision #backswedens #boost #alliancenvidia #softbank #nvidia
Source: Reuters: Health - July 12, 2023 Category: Consumer Health News Source Type: news

First-time CEO picked by trust
North West Anglia Foundation Trust has recruited Mid and South Essex FT’s acting chief executive as its new permanent CEO.
Source: HSJ - July 12, 2023 Category: UK Health Source Type: news

Aurobindo Pharma arm gets USFDA nod for Sevelamer hydrochloride tablets
Aurobindo Pharma Ltd on Wednesday said its wholly-owned subsidiary APL Healthcare has received a final approval from the US health regulator for generic Sevelamer hydrochloride tablets used to control serum phosphorus in patients with chronic kidney disease (CKD) on dialysis. The approval granted by the USFDA to make and market Sevelamer hydrochloride is for tablets of strengths 400 mg and 800 mg, Aurobindo Pharma said.
Source: The Economic Times Healthcare and Biotech News - July 12, 2023 Category: Pharmaceuticals Source Type: news

UK government refusing to match Scottish pay offer that could avert NHS strikes
Strikes by junior doctors and consultants in England this month look certain to go ahead as the BMA highlighted a 'gulf' between the UK government and the Scottish government on doctors' pay.
Source: GP Online News - July 11, 2023 Category: Primary Care Tags: Pay Source Type: news

Urgent 'do not eat' warning to parents over lollipops made with sharp sticks that could injure kids
Food safety watchdogs said that Candy Stars Lollipops - which come in apple, orange, strawberry and assorted fruit flavours - made by Harlow-based Bumerang Ltd have been recalled.
Source: the Mail online | Health - July 11, 2023 Category: Consumer Health News Source Type: news

Dye & Durham signs deal to sell its TM Group business to Aurelius
Dye & Durham Ltd. DND-T has signed a deal to sell its TM Group business to Aurelius in an agreement worth up to £91-million after a British competition regulator took issue with its acquisition of the business in 2021. Under the transaction, Dye & Durham will receive about £50-million in cash at…#dyedurhamltddndt #tmgroup #aurelius #dyedurham #ukltd #cma #wales #matthewproud #unitedkingdom
Source: Reuters: Health - July 10, 2023 Category: Consumer Health News Source Type: news

Daily Mirror appoints Kirk journalist
Niamh Kirk has joined the Daily Mirror as a journalist. Recently, she was a reporter at Caters News Agency in England. Kirk has also was as an account executive at Punch Communications in England and as a researcher at Spring Films Ltd, also in the UK. Kirk has a bachelor’s and master’s degree…#niamhkirk #dailymirror #catersnewsagency #punchcommunications #springfilmsltd #demontfortuniversity
Source: Reuters: Health - July 10, 2023 Category: Consumer Health News Source Type: news

Senior trust CEO takes on top job at second major trust
East Suffolk and North East Essex Foundation Trust chief executive Nick Hulme has been appointed interim chief at Norfolk and Norwich University Hospitals FT, the trusts have announced.
Source: HSJ - July 10, 2023 Category: UK Health Source Type: news

GasLog Partners unitholders OK full GasLog Ltd. takeover
Source: Reuters: Health - July 8, 2023 Category: Consumer Health News Source Type: news

FDA Grants Traditional Approval for Leqembi (lecanemab-irmb) for the Treatment of Alzheimer ’s Disease
TOKYO and CAMBRIDGE, Mass., July 06, 2023 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito,“Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A....
Source: Drugs.com - New Drug Approvals - July 7, 2023 Category: Drugs & Pharmacology Source Type: news

IGC Pharma Secures $12M Credit Facility From O-Bank To Aid Alzheimer ' s Research
IGC Pharma, Inc. IGC has recently secured a $12 million credit from the Hong Kong Branch of O-Bank Co., Ltd. This funding will support IGC's working capital needs primarily related to Alzheimer's research. Notably, IGC-AD1 is currently in Phase 2 of clinical trials as a potential treatment for…#igcpharmaincigc #obankcoltd #igc #hongkong
Source: Reuters: Health - July 7, 2023 Category: Consumer Health News Source Type: news

Alibaba shares rise on report China probe of Ant will end with fine
U.S.-listed shares of Alibaba Group Holding Ltd. climbed ahead of Friday’s market open after a report that a long-running investigation into Ant Group will end with a penalty of at least 8 billion yuan ($1.1 billion). After jumping in Hong Kong, Alibaba’s ADR BABA, 9988, rose 3% after Reuters…#antgroup #hongkong #alibaba #adrbaba #peoplesbankofchina #ant #jackma #marketwatch
Source: Reuters: Health - July 7, 2023 Category: Consumer Health News Source Type: news

FDA Makes Alzheimer ’s Drug Leqembi Widely Accessible
The F.D.A. gave full approval to the drug, but added a black-box warning about safety risks. Medicare said it would cover most of the high cost.
Source: NYT Health - July 7, 2023 Category: Consumer Health News Authors: Pam Belluck Tags: Drugs (Pharmaceuticals) Alzheimer ' s Disease Medicare Clinical Trials Decisions and Verdicts Memory Biogen Inc Eisai Co Ltd Centers for Medicare and Medicaid Services Food and Drug Administration United States Source Type: news

Samsung Elec flags 96% drop in Q2 profit as chip glut persists
[1/3] Traffic passes a Samsung Electronics Co digital billboard in the Times Square area of Manhattan in New York City, U.S. March 2, 2023. REUTERS/Chris Helgren/File Photo SEOUL, July 7 (Reuters) - Samsung Electronics Co Ltd (005930.KS) reported a likely 96% plunge in second-quarter operating…#samsungelectronicsco #timessquare #manhattan #newyorkcity #samsung #joycelee #heekyongyang
Source: Reuters: Health - July 7, 2023 Category: Consumer Health News Source Type: news

Teva ' s Strategic Evaluation: Israeli Pharma Company Mulls Divesting $2B Active Ingredients Unit
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is reportedly considering potential strategic options for its active pharmaceutical ingredients (API) unit, which could include a potential sale. This news comes from individuals privy to the matter, who indicated that the current healthcare asset…#api #teva #richardfrancis #ussupremecourt #gskplc #gsk
Source: Reuters: Health - July 6, 2023 Category: Consumer Health News Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20